Novo Nordisk and US biotech company team up to create obesity pills

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup